Pharma logs 17% growth in Nov; anti-infective therapy drives market demand

Key antibiotic brands like Augmentin (GSK) and Clavam (Alkem) clocked 25 per cent and 29 percent growth, respectively, in November, the data showed

The domestic pharmaceutical market saw its highest growth rate for 2022 in November, at 17.3 per cent, after both volume sales and price growth picked up.
 

Compared to November 2021, when it had clocked 6.6 per cent growth, the Indian Pharmaceutical Market (IPM) posted robust growth numbers last month as anti-infective therapy drove the market demand.
 

Volume growth had slowed in the months of February, March, April, and May, indicating that unit sales in the IPM were declining. The overall IPM growth was in negative territory for these four months.
 

A gradual rebound started in June, but in October again,